NDC 0641-6184-01 - Digoxin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0641-6184
- Requested NDC
- 0641-6184-01
- Package NDCs from labels
- 0641-6184-01, 0641-6184-25
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Effective date
- 2026-03-25
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Digoxin - Hikma Pharmaceuticals USA Inc. | Hikma Pharmaceuticals USA Inc. | 2026-03-25 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0641-6184-01 | Digoxin | 2 mL in 1 AMPULE | INJECTION | 2 | 10 | |
| 0641-6184-25 | Digoxin | 25 in 1 CARTON | INJECTION | 25 | 10 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| DIGOXIN | ACTIVE INGREDIENT | 73K4184T59 | DIGOXIN INJECTION [WEST-WARD PHARMACEUTICALS CORP.] | 1 | |
| DIGOXIN | ACTIVE MOIETY | 73K4184T59 | DIGOXIN INJECTION [WEST-WARD PHARMACEUTICALS CORP.] | 1 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | DIGOXIN INJECTION [WEST-WARD PHARMACEUTICALS CORP.] | 1 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | DIGOXIN INJECTION [WEST-WARD PHARMACEUTICALS CORP.] | 1 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | DIGOXIN INJECTION [WEST-WARD PHARMACEUTICALS CORP.] | 1 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | DIGOXIN INJECTION [WEST-WARD PHARMACEUTICALS CORP.] | 1 | |
| SODIUM PHOSPHATE | INACTIVE INGREDIENT | SE337SVY37 | DIGOXIN INJECTION [WEST-WARD PHARMACEUTICALS CORP.] | 1 | |
| SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | 22ADO53M6F | DIGOXIN INJECTION [WEST-WARD PHARMACEUTICALS CORP.] | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | DIGOXIN INJECTION [WEST-WARD PHARMACEUTICALS CORP.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hand sanitizer 2oz 2pk original | ETHYL ALCOHOL | Rejoice International Corp. | 06dc1730-216a-8b4d-e063-6294a90a4184 | 2023-10-04 | Warnings | 3K9958V90M |
| Hand sanitizer 1.8oz with extra clip original | ETHYL ALCOHOL | Zhejiang Guoyao Jingyue Aerosol Co., Ltd. | 06dcf8dc-0831-475e-e063-6394a90a9fef | 2023-10-04 | Warnings | 3K9958V90M |
| Hand sanitizer 2oz 2pk original | ETHYL ALCOHOL | Zhejiang Guoyao Jingyue Aerosol Co., Ltd. | 06dd2427-097c-b0fa-e063-6294a90a4f82 | 2023-10-04 | Warnings | 3K9958V90M |
| Hand sanitizer 1.8oz with extra clip original | ETHYL ALCOHOL | Rejoice International Corp. | 06da0cc1-95f2-4f88-e063-6394a90a25ea | 2023-10-03 | Warnings | 3K9958V90M |
| Hand Sanitizing Wipes | HAND SANITIZING WIPES | Innovative Biodefense | b01d3c2c-056c-314c-e053-2a95a90a42f4 | 2023-09-16 | Warnings | 3K9958V90M |
| ANUBISMED | HA HYALURONIC | ANUBIS COSMETICS SL | eac771e2-4c1b-3808-e053-2995a90ac5fc | 2023-09-05 | Warnings | 6DC9Q167V3 059QF0KO0R |
| AnubisMed | SPF 50 BROAD SPECTRUM PROTECTION FLUID EMULSION | ANUBIS COSMETICS SL | e99d92c4-8768-9c0a-e053-2a95a90a609e | 2023-09-05 | Warnings | 6DC9Q167V3 059QF0KO0R XF417D3PSL |
| AnubisMed | AZELAIC ACID, SALICYLIC ACID | ANUBIS COSMETICS SL | ebf3153d-30f5-54e4-e053-2995a90a74b1 | 2023-09-05 | Warnings | 6DC9Q167V3 059QF0KO0R 3K9958V90M |
| AnubisMed | GLYCOLIC ACID, CITRIC ACID, LACTIC ACID, KOJIC ACID | ANUBIS COSMETICS SL | eca95dde-cb57-2ab6-e053-2995a90af84f | 2023-09-05 | Warnings | 6DC9Q167V3 059QF0KO0R 3K9958V90M |
| AnubisMed | SODIUM BICARBONATE, ALOE BARBADENSIS LEAF JUICE, IMIDAZOLIDINYL UREA | ANUBIS COSMETICS SL | ebf4b3ab-34e1-185a-e053-2a95a90ace3a | 2023-09-05 | Warnings | 059QF0KO0R |
| Anubis Barcelona | GLYCERIN, SORBITOL, ALOE BARBADENSIS LEAF JUICE | ANUBIS COSMETICS SL | eb651769-4d98-2b3b-e053-2a95a90a36b0 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona | DMAE | ANUBIS COSMETICS SL | f22b212d-d21d-5984-e053-2995a90a683e | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona | DMAE, ZIRHAFIRM | ANUBIS COSMETICS SL | f2274f8c-08aa-eb02-e053-2a95a90a3998 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona | PEG-40 HYDROGENATED CASTOR OIL, PROPYLENE GLYCOL, ALLANTOIN | ANUBIS COSMETICS SL | eb9244ea-6102-3cbe-e053-2a95a90ab8f6 | 2023-09-01 | Warnings | 6DC9Q167V3 059QF0KO0R 3K9958V90M |
| Anubis Barcelona | PROTEOGLYCAN, GLYCERIN, BUTYLENE GLYCOL | ANUBIS COSMETICS SL | ebdddcec-f5da-51fe-e053-2995a90a6167 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona Regul Oil | PROPYLENE GLYCOL, PANTHENOL, THIAMINE HCL | ANUBIS COSMETICS SL | eb8e5beb-4452-58c2-e053-2a95a90a66e0 | 2023-09-01 | Warnings | 6DC9Q167V3 059QF0KO0R 3K9958V90M |
| Anubis Barcelona Protective Line | ETHYLHEXYL METHOXYCINNAMATE, BUTYL METHOXYDIBENZOYLMETHANE, ETHYLHEXYL SALICYLATE, OCTOCRYLENE | ANUBIS COSMETICS SL | ec83846f-11c0-8f59-e053-2995a90ab9d2 | 2023-09-01 | Warnings | 6DC9Q167V3 059QF0KO0R |
| Anubis Barcelona Regul Oil | CETEARYL ETHYLHEXANOATE, PROPYLENE GLYCOL, GLYCERYL STEARATE SE | ANUBIS COSMETICS SL | eb68c3ab-7835-1a1c-e053-2995a90a0d66 | 2023-09-01 | Warnings | 6DC9Q167V3 059QF0KO0R 3K9958V90M |
| Anubis Barcelona | PROPANEDIOL, GLYCERIN, MAGNESIUM ASCORBYL PHOSPHATE | ANUBIS COSMETICS SL | eb53cba1-0509-43bc-e053-2995a90a5e09 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona Spa Line | ORYZA SATIVA (RICE) STARCH, PERLITE, PALMITIC ACID | ANUBIS COSMETICS SL | eb01a962-ab38-18ec-e053-2995a90acdeb | 2023-09-01 | Warnings | 6DC9Q167V3 059QF0KO0R 3K9958V90M |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.